Drug Shows Promise Against Autoimmune Disease Scleroderma
MONDAY, Oct. 10, 2022 -- Researchers report early success with using an existing rheumatoid arthritis (RA) drug to treat systemic sclerosis, a rare but potentially devastating autoimmune condition.
The disease, a subset of scleroderma, hardens the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 10, 2022 Category: General Medicine Source Type: news
Tofacitinib Shows Promise Against Autoimmune Disease Scleroderma
MONDAY, Oct. 10, 2022 -- Researchers report early success with using an existing rheumatoid arthritis (RA) drug to treat systemic sclerosis, a rare but potentially devastating autoimmune condition.
The disease, a subset of scleroderma, hardens the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 10, 2022 Category: General Medicine Source Type: news
No Special Heart Risk With JAK Inhibitors, Study Finds
(MedPage Today) -- Patients taking Janus kinase (JAK) inhibitors for rheumatoid arthritis experienced similar cardiovascular outcomes as those using the tumor necrosis factor (TNF) blocker adalimumab (Humira), analysis of French national registry... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - October 7, 2022 Category: Cardiology Source Type: news
Pirfenidone Promising for RA-Linked Interstitial Lung Disease
TUESDAY, Oct. 4, 2022 -- Pirfenidone may slow the rate of decline of forced vital capacity (FVC) among patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD), according to a study published online Sept. 5 in The Lancet... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 4, 2022 Category: Pharmaceuticals Source Type: news
Clinical Predictors of Methotrexate Response in RA Patients Clinical Predictors of Methotrexate Response in RA Patients
Could certain factors determine treatment response to methotrexate in rheumatoid arthritis patients? A new study uses a machine learning approach to identify potential predictors.Arthritis Research & Therapy (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 4, 2022 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news
Severe COVID-19 –Related Outcomes Found Worse in Men With RA Severe COVID-19 –Related Outcomes Found Worse in Men With RA
A retrospective electronic health record study of patients with rheumatoid arthritis and COVID-19 showed that men had more baseline comorbidities and increased risk of COVID-19 outcomes than females.Medscape Medical News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - September 29, 2022 Category: Infectious Diseases Tags: Rheumatology News Source Type: news
Group Therapy for Insomnia Studied in RA Patients
TUESDAY, Sept. 20, 2022 -- For patients with rheumatoid arthritis (RA) and insomnia, nurse-led group-based cognitive behavioral therapy for insomnia (CBT-I) does not have an impact on sleep efficiency measured immediately after the intervention, but... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 20, 2022 Category: Pharmaceuticals Source Type: news
Lupus, Psoriasis Patients May Face Greater Dangers After Heart Attack
THURSDAY, Sept. 15, 2022 -- People with autoimmune disorders like lupus, rheumatoid arthritis or psoriasis who suffer a heart attack are more likely to die or develop severe heart-related complications in the aftermath, a new study shows.
A heart... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 15, 2022 Category: General Medicine Source Type: news
Predicting Fractures in RA: Is FRAX Useful in the Modern Treatment Era?
(MedPage Today) -- AUSTIN, Texas – The Fracture Risk Assessment Tool (FRAX) for predicting risk of osteoporotic fractures appeared valid for rheumatoid arthritis (RA) patients treated in the era of biologics.
In a Canadian database study... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - September 11, 2022 Category: Endocrinology Source Type: news
Lupin, DKSH enter pact to commercials Alvotech biosimilars in Philippines
The biosimilars planned under this agreement include biosimilar Prolia (denosumab 60mg/ml) and Xgeva (denosumab 70 mg/ml) for treating osteoporosis, Simponi (golimumab) for treating rheumatoid arthritis, and Eylea (aflibercept) against wet-age macular degeneration as well as two undisclosed proposed biosimilars for immunology and oncology. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 7, 2022 Category: Pharmaceuticals Source Type: news
Pirfenidone Shows Hints of Benefit for RA-Related Lung Disease
(MedPage Today) -- BARCELONA -- Rheumatoid arthritis patients with existing interstitial lung disease (ILD) had less decline in lung function when receiving the antifibrotic agent pirfenidone (Esbriet) relative to placebo in a randomized trial... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - September 6, 2022 Category: Rheumatology Source Type: news
One Young Mom's Journey With Rheumatoid Arthritis
TUESDAY, Sept. 6, 2022 -- Nearly 10 years ago, Tania Morales was a busy working mom when she was suddenly struck by pain, joint stiffness and exhaustion.“I felt alarmed, where it got to a point where I was telling my husband,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 6, 2022 Category: General Medicine Source Type: news
Study Reassures on HCQ Heart Risks in Rheumatoid Arthritis
(MedPage Today) -- Among U.S. veterans receiving hydroxychloroquine (HCQ) as long-term therapy for rheumatoid arthritis, development of long QT syndrome was rare and not markedly more common compared with similar patients treated with other agents... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - September 2, 2022 Category: Rheumatology Source Type: news
AI Model Can Quantify Radiographic Joint Damage in RA
FRIDAY, Sept. 2, 2022 -- An international competition resulted in the development of algorithms that provide feasible, quick, and accurate methods to quantify joint damage in rheumatoid arthritis (RA), according to a study published online Aug. 29... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 2, 2022 Category: Pharmaceuticals Source Type: news
Lupus, MS and Other Autoimmune Disorders Raise Heart Risks
WEDNESDAY, Aug. 31, 2022 -- Research has linked heart disease to specific autoimmune diseases such as rheumatoid arthritis and lupus. Now, a huge study shows that autoimmune diseases as a group increase your chances of developing heart... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 31, 2022 Category: General Medicine Source Type: news
